The influence of dexmedetomidine on remifentanil‑induced hyperalgesia and the sex differences

Qiu,Haidi; Sun,Zhe; Shadhiya,Fathima; Arulthas,Renuka; Priya,Gita  Vishnu; Christopher,Pariyatha; Muhammad,Zulaihat; Yu,Yonghao

doi:10.3892/etm.2018.6641

The influence of dexmedetomidine on remifentanil‑induced hyperalgesia and the sex differences

Authors:
- Haidi Qiu
- Zhe Sun
- Fathima Shadhiya
- Renuka Arulthas
- Gita Vishnu Priya
- Pariyatha Christopher
- Zulaihat Muhammad
- Yonghao Yu
View Affiliations

Affiliations: Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China, Department of International Medical School, Tianjin Medical University, Tianjin 300070, P.R. China
Published online on: August 22, 2018 https://doi.org/10.3892/etm.2018.6641
Pages: 3596-3602

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the clinical settings, patients often develop opioid‑induced hyperalgesia (OIH) after utilization of high dose intra‑operative remifentanil. Systemic α2 agonists, including dexmedetomidine, are believed to reduce pain and opioid requirements after surgery, thus decreasing the incidence of hyperalgesia. The present study aimed to investigate the effect of dexmedetomidine on remifentanil‑induced hyperalgesia and explored the sex differences. A total of 48 patients (24 male, 24 female) with an American Society of Anesthesiologists physical status of I‑II that were undergoing thyroidectomy were randomly assigned to one of the following six groups: Male controlled group (MC) and female controlled group (FC) (group MC, n=8 and group FC, n=8), which received a preoperative placebo of 0.2 µg.kg‑1 normal saline and intraoperative remifentanil 0.2 µg.kg‑1.min‑1; male and female group with low‑dose dexmedetomidine (group MD1, n=8 and group FD1, n=8), which received preoperative dexmedetomidine 0.2 µg.kg‑1 and intraoperative remifentanil 0.2 µg.kg‑1.min‑1; and male and female groups with high‑dose dexmedetomidine (group MD2, n=8 and group FD2, n=8), which received dexmedetomidine 0.6 µg.kg‑1 and intraoperative remifentanil 0.2 µg.kg‑1.min‑1. Result indicated that the visual analog scale (VAS) scores and morphine dosing frequency were significantly higher in MC and FC groups compared with the other same sex groups. Furthermore, the mechanical hyperalgesia threshold and patients' analgesia satisfaction score after surgery were significantly lower in MC and FC groups. Notably, the frequency of post‑operative chills, nausea and vomiting were significantly lower in groups MD1, MD2, FD1 and FD2. The present findings indicated that low‑ and high‑dose dexmedetomidine injection significantly decreased the patient's risk of enhanced pain intensity and increased postoperative morphine dosing caused by remifentanil‑induced hyperalgesia. These findings suggest that the influence of dexmedetomidine displayed minimal significant differences between sex. Trial registration no., IRB2018‑YX‑001 (Name of registry: Institutional Medical Ethics Committee of Tianjin Medical University General Hospital; date of registration: February 1, 2016).

View Figures

View References

1	Egan TD: Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet. 29:80–94. 1995. View Article : Google Scholar : PubMed/NCBI
2	Yu EH, Tran DH, Lam SW and Irwin MG: Remifentanil tolerance and hyperalgesia: Short-term gain, long-term pain? Anaesthesia. 71:1347–1362. 2016. View Article : Google Scholar : PubMed/NCBI
3	Kim SH, Stoicea N, Soghomonyan S and Bergese SD: Remifentanil-acute opioid tolerance and opioid-induced hyperalgesia: A systematic review. Am J Ther. 22:e62–e74. 2015. View Article : Google Scholar : PubMed/NCBI
4	Belgrade M and Hall S: Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med. 11:1819–1826. 2010. View Article : Google Scholar : PubMed/NCBI
5	Ge DJ, Qi B, Tang G and Li JY: Intraoperative dexmedetomidine promotes postoperative analgesia and recovery in patients after abdominal hysterectomy: A double-blind, randomized clinical trial. Sci Rep. 6:215142016. View Article : Google Scholar : PubMed/NCBI
6	Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI and Chauvin M: Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 103:147–155. 2005. View Article : Google Scholar : PubMed/NCBI
7	Yalcin N, Uzun ST, Reisli R, Borazan H and Otelcioglu S: A comparison of ketamine and paracetamol for preventing remifentanil induced hyperalgesia in patients undergoing total abdominal hysterectomy. Int J Med Sci. 9:327–333. 2012. View Article : Google Scholar : PubMed/NCBI
8	Choi E, Lee H, Park HS, Lee GY, Kim YJ and Baik HJ: Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia. Korean J Anesthesiol. 68:476–480. 2015. View Article : Google Scholar : PubMed/NCBI
9	Lenz H, Raeder J, Draegni T, Heyerdahl F, Schmelz M and Stubhaug A: Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain. 152:1289–1297. 2011. View Article : Google Scholar : PubMed/NCBI
10	Tröster A, Sittl R, Singler B, Schmelz M, Schüttler J and Koppert W: Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology. 105:1016–1023. 2006. View Article : Google Scholar : PubMed/NCBI
11	Comelon M, Raeder J, Stubhaug A, Nielsen CS, Draegni T and Lenz H: Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia. Br J Anaesth. 116:524–530. 2016. View Article : Google Scholar : PubMed/NCBI
12	Sheehy KA, Finkel JC, Darbari DS, Guerrera MF and Quezado ZM: Dexmedetomidine as an adjuvant to analgesic strategy during vaso-occlusive episodes in adolescents with sickle-cell disease. Pain Pract. 15:E90–E97. 2015. View Article : Google Scholar : PubMed/NCBI
13	Kamibayashi T and Maze M: Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 93:1345–1349. 2000. View Article : Google Scholar : PubMed/NCBI
14	Zhang X and Bai Z: New therapeutic uses for an alpha2 adrenergic receptor agonist-dexmedetomidine in pain management. Neurosci Lett. 561:7–12. 2014. View Article : Google Scholar : PubMed/NCBI
15	Blaudszun G, Lysakowski C, Elia N and Tramèr MR: Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: Systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 116:1312–1322. 2012. View Article : Google Scholar : PubMed/NCBI
16	Gold MS, Dastmalchi S and Levine JD: Alpha 2 adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain. 69:179–190. 1997. View Article : Google Scholar : PubMed/NCBI
17	Lee M, Silverman SM, Hansen H, Patel VB and Manchikanti L: A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 14:145–161. 2011.PubMed/NCBI
18	Zhong WG, Ge XY, Zhu H, Liang X, Gong HX, Zhong M and Xiao X: Dexmedetomidine for antiemesis in gynecologic surgery: A meta-analysis of randomized controlled trials. Int J Clin Exp Med. 8:14566–14576. 2015.PubMed/NCBI
19	Jin S, Liang DD, Chen C, Zhang M and Wang J: Dexmedetomidine prevent postoperative nausea and vomiting on patients during general anesthesia: A PRISMA-compliant meta analysis of randomized controlled trials. Medicine (Baltimore). 96:e57702017. View Article : Google Scholar : PubMed/NCBI
20	Bajwa SJ, Gupta S, Kaur J, Singh A and Parmar S: Reduction in the incidence of shivering with perioperative dexmedetomidine: A randomized prospective study. J Anaesthesiol Clin Pharmacol. 28:86–91. 2012. View Article : Google Scholar : PubMed/NCBI
21	Kumar A, Shinha C, Kumar A and Kumari P: The effect of intravenous dexmedetomidine compared to propofol on patients hemodynamics as a sedative in brachial plexus block: A comparative study. Anesth Essays Res. 11:201–205. 2017. View Article : Google Scholar : PubMed/NCBI
22	Fletcher D and Martinez V: How can we prevent opioid induced hyperalgesia in surgical patients? Br J Anaesth. 116:447–449. 2016. View Article : Google Scholar : PubMed/NCBI
23	Gu X, Wu X, Liu Y, Cui S and Ma Z: Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: The preventive effect of ketamine. Mol Pain. 5:762009. View Article : Google Scholar : PubMed/NCBI
24	Ye L, Xiao L, Bai X, Yang SY, Li Y and Chen Y, Cui Y and Chen Y: Spinal mitochondrial-derived ROS contributes to remifentanil-induced postoperative hyperalgesia via modulating NMDA receptor in rats. Neurosci Lett. 634:79–86. 2016. View Article : Google Scholar : PubMed/NCBI
25	Sun J, Lin H, He G, Lin W and Yang J: Magnesium sulphate attenuate remifentanil-induced postoperative hyperalgesia via regulating tyrosine phosphorylation of the NR₂B subunit of the NMDA receptor in the spinal cord. BMC Anesthesiol. 17:302017. View Article : Google Scholar : PubMed/NCBI
26	Angst MS, Koppert W, Pahl I, Clark DJ and Schmelz M: Short-term infusion of the µ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 106:49–57. 2003. View Article : Google Scholar : PubMed/NCBI
27	Oladosu FA, Conrad MS, O'buckley SC, Rashid NU, Slade GD and Nackley AG: Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia. PLoS One. 10:e01357112015. View Article : Google Scholar : PubMed/NCBI
28	Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, Zhang ET, Malan TP Jr, Ossipov MH, Lai J and Porreca F: Dynorphin promotes abnormal pain and spinal opioid antinoceceptive tolerance. J Neurosci. 20:7074–7079. 2000. View Article : Google Scholar : PubMed/NCBI
29	Jensen KB, Lonsdorf TB, Schalling M, Kosek E and Ingvar M: Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One. 4:e60162009. View Article : Google Scholar : PubMed/NCBI
30	Youssef F, Pater A and Shehata M: Opioid-induced hyperalgesia. J Pain Relief. 4:1832015.
31	Li A, Yuen VM, Goulay-Dufay S and Kwok PC: Pharmacokinetics and pharmacodynamics of dexmedetomidine. Drug Dev Ind Pharm. 42:1917–1927. 2016. View Article : Google Scholar : PubMed/NCBI
32	Yuan Y, Sun Z, Chen Y, Zheng Y, Xie KL, He Y, Wang Z, Wang GL and Yu YH: Prevention of remifentanil induced postoperative hyperalgesia by dexmedetomidine via regulation the trafficking and function of spinal NMDA receptors as well as PKC and CaMKII level in vivo and in vitro. PLoS One. 12:e01713482017. View Article : Google Scholar : PubMed/NCBI
33	Fairbanks CA, Kitto KF, Nguyen HO, Stone LS and Wilcox GL: Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord. Anesthesiology. 110:638–647. 2009. View Article : Google Scholar : PubMed/NCBI
34	Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ and Wilcox GL: α2c-adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 300:282–290. 2001. View Article : Google Scholar
35	Lee C, Kim YD and Kim JN: Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia. Korean J Anesthesiol. 64:301–307. 2013. View Article : Google Scholar : PubMed/NCBI
36	Yu Z, Wu W, Wu X, Lei H, Gong C and Xu S: Protective effects of dexmedetomidine combined with flurbiprofen axetil on remifentanil-induced hyperalgesia: A randomized controlled trial. Exp Ther Med. 12:2622–2628. 2016. View Article : Google Scholar : PubMed/NCBI